Skip to main content
SpringerLink
Log in

Botulinum Toxin Use in Movement Disorders and Spasticity

  • Chapter
  • First Online:
Movement Disorders Curricula

  • 1388 Accesses

Abstract

Ever since botulinum toxin was first used as a treatment for strabismus in 1980, it has become instrumental in the treatment of a myriad of conditions with focal muscle overactivity including cosmetic uses to treat wrinkles. Botulinum toxin use in the treatment of movement disorders including dystonia, hemifacial spasm, tremor, and tics is discussed along with some emphasis on the targeted muscles. Treatment of sialorrhea and spasticity is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Albanese A, Bentivoglio AR, Colosimo C, Galardi G, Maderna L, Tonali P. Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry. 1996;60:693–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Albanese A, Bhatia K, Bessman SB, DeLong MR, Fahn S, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863–73.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Beneke R, Frei K, Comella C. Treatment of cervical dystonia. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 29–41.

    Google Scholar 

  4. Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospams and hemifacial spasm. J Neurol. 2002;249:64–8.

    Article  CAS  PubMed  Google Scholar 

  5. Cardoso F, Bhidayasiri, Truong D. Treatment of oromandibular dystonia. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 53–60.

    Google Scholar 

  6. Cecini M, Pavese C, Comelli M, Carlisi E, Sala V, Bejor M, Toffola ED. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type a. Plast Reconstr Surg. 2013;132(5):1255–64.

    Article  CAS  PubMed  Google Scholar 

  7. Choi KH, Rho SH, Lee JM, Jeon JH, Park SY, Kim J. Botulinum toxin injections of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg. 2013;66(8):1058–63.

    Article  PubMed  Google Scholar 

  8. Colosimo C, Tiple D, Berardelli A. Treatment of blepharospam. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 49–52.

    Google Scholar 

  9. Das CP, Truong DD, Hallett M. Treatment of focal hand dystonia. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 61–75.

    Google Scholar 

  10. Dressler D, Bigalke H. Pharmacology of botulinum toxin drugs. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 13–22.

    Google Scholar 

  11. Frei K, Roggenkamper P. Treatment of hemifacial spasm. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 43–47.

    Google Scholar 

  12. Frucht SJ. Embouchure dystonia – portrait of a task-specific cranial dystonia. Mov Disord. 2009;24(12):1752–62.

    Article  PubMed  Google Scholar 

  13. Frucht SJ, Fahn S, Greene PE, O’Brien C, Gelb M, Truong DD, Welsh J, Facotr S, Ford B. The natural history of embouchure dystonia. Mov Disord. 2001;16(5):889–906.

    Article  Google Scholar 

  14. Fung VSC, Jinnah HA, Bhati K, Vidailhet M. Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes. Mov Disord. 2013;28(7):889–98.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hong JS, Sathe GG, Niyonkuru C, Munin MC. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve. 2012;46(4):535–9.

    Article  PubMed  Google Scholar 

  16. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013;28(7):1001–12.

    Article  CAS  PubMed  Google Scholar 

  17. Jedynak CP, Bonnet AM, Agid Y. Tremor and idiopathic dystonia. Mov Disord. 1991;6:230–6.

    Article  CAS  PubMed  Google Scholar 

  18. Jinnah HA, Berardelli A, Comella C, DeFazio G, DeLong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR. The focal dystonias: current views and challenges for future research. Mov Disord. 2013;28(7):926–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. Spasticity: etiology, evaluation, management, and the role of botulinum toxin. In: Mayer NH, Simpson DM, editors. WE MOVE. 2002:16-26.

    Google Scholar 

  20. Nobrega AC, Rodrigues B, Melo A. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson’s disease patients? Clin Neurol Neurosurg. 2009;111(5):430–2.

    Article  PubMed  Google Scholar 

  21. Pathak MS, Brashear A. Spasticity. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 101–13.

    Google Scholar 

  22. Satoh M, Narita M, Tomimoto H. Three cases of focal embouchure dystonia: classifications and successful therapy using a dental splint. Eur Neurol. 2011;66(2):85–90.

    Article  PubMed  Google Scholar 

  23. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044–9.

    Article  CAS  PubMed  Google Scholar 

  24. Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol C, Goetz CG, Sampaio C. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26 Suppl 3:S42–80.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sheffield JK, Jankovic J. Botulinum toxin in tic disorders and essential hand and head tremor. Manual of botulinum toxin therapy. Cambridge University Press; New York 2009. p. 195–204.

    Google Scholar 

  26. Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1699–706.

    Article  CAS  PubMed  Google Scholar 

  27. Singer HS. Treatment of Tics and Tourette’s syndrome. Curr Treat Options Neurol. 2010;12:539–61.

    Article  PubMed  Google Scholar 

  28. Stamelou M, Edwards MJ, Hallett M, Bhatia KP. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain. 2012;135:1668–81.

    Article  PubMed  Google Scholar 

  29. Thompson PD, Obeso JA, Delgado G, Gallego J, Marsden CD. Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry. 1986;49:651–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21(12):1740–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Loma Linda University Medical Center, 11370 Anderson St. Suite B-100, Loma Linda, CA, USA

    Karen Frei MD

  2. Parkinson’s and Movement Disorder Institute, 9940 Talbert Avenue, Suite 204, Fountain Valley, CA, 92708, USA

    Daniel Truong MD

Authors
  1. Karen Frei MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Truong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Truong MD .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Transilvania University, Brasov, Romania

    Cristian Falup-Pecurariu

  2. Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Lisbon, Portugal

    Joaquim Ferreira

  3. National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain

    Pablo Martinez-Martin

  4. Centre of Excellence, King’s College London, National Parkinson Foundation Centre of Excellence King’s College, London, United Kingdom

    Kallol Ray Chaudhuri

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Wien

About this chapter

Cite this chapter

Frei, K., Truong, D. (2017). Botulinum Toxin Use in Movement Disorders and Spasticity. In: Falup-Pecurariu, C., Ferreira, J., Martinez-Martin, P., Chaudhuri, K. (eds) Movement Disorders Curricula. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1628-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1628-9_37

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1627-2

  • Online ISBN: 978-3-7091-1628-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation